{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:08:10Z","timestamp":1786975690130,"version":"build-2736575974"},"reference-count":60,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.29043","type":"journal-article","created":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T02:15:58Z","timestamp":1607739358000},"page":"e2029043","source":"Crossref","is-referenced-by-count":23,"title":["Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine"],"prefix":"10.1001","volume":"3","author":[{"given":"Max Jordan","family":"Nguemeni Tiako","sequence":"first","affiliation":[{"name":"Medical student, Yale School of Medicine, New Haven, Connecticut"},{"name":"Center for Emergency Care and Policy Research, Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Urban Health Lab, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Culhane","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"South","sequence":"additional","affiliation":[{"name":"Center for Emergency Care and Policy Research, Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Urban Health Lab, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu K.","family":"Srinivas","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary F.","family":"Meisel","sequence":"additional","affiliation":[{"name":"Center for Emergency Care and Policy Research, Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia"},{"name":"Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"issue":"1","key":"zoi200923r1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jsat.2014.07.007","article-title":"Recent trends in treatment admissions for prescription opioid abuse during pregnancy.","volume":"48","author":"Martin","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"zoi200923r2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15585\/mmwr.mm6801a2","article-title":"Evaluation of state-mandated reporting of neonatal abstinence syndrome\u2014six states, 2013-2017.","volume":"68","author":"Jilani","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"zoi200923r3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/AOG.0000000000002426","article-title":"Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.","volume":"131","author":"Smid","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"zoi200923r4","doi-asserted-by":"publisher","first-page":"B5","DOI":"10.1016\/j.ajog.2019.03.022","article-title":"Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine.","volume":"221","author":"Ecker","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"zoi200923r5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.","volume":"79","author":"Jones","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"24","key":"zoi200923r6","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure.","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi200923r7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/aje\/kwu190","article-title":"Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.","volume":"180","author":"Brogly","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"10","key":"zoi200923r8","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.3390\/ijerph8104102","article-title":"Improving public health through access to and utilization of medication assisted treatment.","volume":"8","author":"Kresina","year":"2011","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"zoi200923r9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11606-011-1962-8","article-title":"Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.","volume":"27","author":"Schackman","year":"2012","journal-title":"J Gen Intern Med"},{"key":"zoi200923r10","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"5","key":"zoi200923r11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/AOG.0000000000003503","article-title":"Methadone, buprenorphine, or detoxification for management of perinatal opioid use disorder: a cost-effectiveness analysis.","volume":"134","author":"Premkumar","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"zoi200923r12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder.","volume":"133","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"key":"zoi200923r13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren\u2019t physicians prescribing more buprenorphine?","volume":"78","author":"Huhn","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"zoi200923r14","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.amepre.2018.02.006","article-title":"Prescribing practices of rural physicians waivered to prescribe buprenorphine.","volume":"54","author":"Andrilla","year":"2018","journal-title":"Am J Prev Med"},{"issue":"1","key":"zoi200923r15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1377\/hlthaff.2018.05145","article-title":"Trends in buprenorphine prescribing by physician specialty.","volume":"38","author":"Wen","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"zoi200923r18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12963-015-0044-2","article-title":"The county health rankings: rationale and methods.","volume":"13","author":"Remington","year":"2015","journal-title":"Popul Health Metr"},{"issue":"31","key":"zoi200923r21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization\u2014United States, 1999-2014.","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"zoi200923r24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of US physicians trained to treat opioid use disorder.","volume":"13","author":"Rosenblatt","year":"2015","journal-title":"Ann Fam Med"},{"issue":"1","key":"zoi200923r25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jrh.2019.35.issue-1","article-title":"Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update.","volume":"35","author":"Andrilla","year":"2019","journal-title":"J Rural Health"},{"issue":"1","key":"zoi200923r26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12887-019-1718-x","article-title":"A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome.","volume":"19","author":"Wolf","year":"2019","journal-title":"BMC Pediatr"},{"issue":"3","key":"zoi200923r27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jama.2019.18913","article-title":"Trends in buprenorphine treatment in the United States, 2009-2018.","volume":"323","author":"Olfson","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"zoi200923r28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1162\/qjec.2010.125.1.417","article-title":"Was postwar suburbanization \u201cwhite flight\u201d? evidence from the black migration.","volume":"125","author":"Boustan","year":"2010","journal-title":"Q J Econ"},{"key":"zoi200923r29","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment.","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"zoi200923r30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City.","volume":"40","author":"Hansen","year":"2013","journal-title":"J Behav Health Serv Res"},{"issue":"4","key":"zoi200923r31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States.","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"zoi200923r32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jsat.2018.07.008","article-title":"Comparison between buprenorphine provider availability and opioid deaths among US counties.","volume":"93","author":"Jones","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"zoi200923r33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/ADM.0000000000000523","article-title":"Disparities between US opioid overdose deaths and treatment capacity: a geospatial and descriptive analysis.","volume":"13","author":"Langabeer","year":"2019","journal-title":"J Addict Med"},{"issue":"3","key":"zoi200923r34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1370\/afm.2384","article-title":"Comparing buprenorphine-prescribing physicians across nonmetropolitan and metropolitan areas in the United States.","volume":"17","author":"Lin","year":"2019","journal-title":"Ann Fam Med"},{"issue":"12","key":"zoi200923r35","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1377\/hlthaff.2019.00859","article-title":"In rural areas, buprenorphine waiver adoption since 2017 driven by nurse practitioners and physician assistants.","volume":"38","author":"Barnett","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"zoi200923r36","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/08897077.2016.1146649","article-title":"Factors associated with buprenorphine versus methadone use in pregnancy.","volume":"37","author":"Krans","year":"2016","journal-title":"Subst Abus"},{"issue":"1","key":"zoi200923r37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jsat.2017.06.005","article-title":"Association of methadone dose with substance use and treatment retention in pregnant and postpartum women with opioid use disorder.","volume":"80","author":"Wilder","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"zoi200923r38","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/00952990.2017.1363218","article-title":"Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.","volume":"44","author":"Johnson","year":"2018","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"zoi200923r39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/maq.12232","article-title":"To be free and normal: addiction, governance, and the therapeutics of buprenorphine.","volume":"29","author":"Harris","year":"2015","journal-title":"Med Anthropol Q"},{"issue":"5","key":"zoi200923r40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/00952990.2015.1059625","article-title":"Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.","volume":"41","author":"Holbrook","year":"2015","journal-title":"Am J Drug Alcohol Abuse"},{"key":"zoi200923r41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2019.11.004","article-title":"Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: a long-term study.","volume":"110","author":"Ling","year":"2020","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"zoi200923r42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ajog.2019.02.056","article-title":"Maternal self-harm deaths: an unrecognized and preventable outcome.","volume":"221","author":"Mangla","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"zoi200923r43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/08897077.2018.1488336","article-title":"Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states.","volume":"40","author":"Patrick","year":"2019","journal-title":"Subst Abus"},{"issue":"8","key":"zoi200923r44","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13456","article-title":"Association of pregnancy and insurance status with treatment access for opioid use disorder.","volume":"3","author":"Patrick","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi200923r45","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/AOG.0b013e3181eeb630","article-title":"Obstetrician-gynecologists\u2019 approach to well-woman care.","volume":"116","author":"Morgan","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"May","key":"zoi200923r46","article-title":"Geographic location of buprenorphine-waivered physicians and integration with health systems.","volume":"115","author":"Saloner","year":"2020","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"zoi200923r47","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ajog.2019.01.226","article-title":"Medical specialty of buprenorphine prescribers for pregnant women with opioid use disorder.","volume":"220","author":"Hollander","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi200923r48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine.","volume":"12","author":"Hutchinson","year":"2014","journal-title":"Ann Fam Med"},{"issue":"9","key":"zoi200923r49","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s11606-007-0264-7","article-title":"Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians.","volume":"22","author":"Cunningham","year":"2007","journal-title":"J Gen Intern Med"},{"issue":"9","key":"zoi200923r50","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","article-title":"Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.","volume":"23","author":"Walley","year":"2008","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi200923r51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/COGRM.1000223","article-title":"Snead C, Schulkin J. Obstetrician-gynecologists\u2019 referral practices for substance use during pregnancy.","volume":"4","author":"H. Coleman-Cowger V","year":"2018","journal-title":"Clin Obstet Gynecol Reprod Med."},{"issue":"1","key":"zoi200923r52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13722-017-0083-z","article-title":"Screening, treatment initiation, and referral for substance use disorders.","volume":"12","author":"Bernstein","year":"2017","journal-title":"Addict Sci Clin Pract"},{"issue":"6","key":"zoi200923r53","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"Emergency department\u2013initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention.","volume":"32","author":"D\u2019Onofrio","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"16","key":"zoi200923r54","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department\u2013initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial.","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"key":"zoi200923r55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1108\/amso","article-title":"Two tiers of biomedicalization: methadone, buprenorphine, and the racial politics of addiction treatment.","volume":"14","author":"Hansen","year":"2012","journal-title":"Crit Perspect Addict"},{"issue":"4","key":"zoi200923r56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jama.2018.20851","article-title":"Association among county-level economic factors, clinician supply, metropolitan or rural location, and neonatal abstinence syndrome.","volume":"321","author":"Patrick","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"zoi200923r57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/ADM.0000000000000175","article-title":"Reproductive health needs among substance use disorder treatment clients.","volume":"10","author":"Terplan","year":"2016","journal-title":"J Addict Med"},{"issue":"5","key":"zoi200923r58","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1016\/j.whi.2013.06.006","article-title":"Medicaid covered births, 2008 through 2010, in the context of the implementation of health reform.","volume":"23","author":"Markus","year":"2013","journal-title":"Womens Health Issues"},{"issue":"2","key":"zoi200923r59","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1542\/hpeds.2019-0221","article-title":"An update on the burden of neonatal abstinence syndrome in the United States.","volume":"10","author":"Ramphul","year":"2020","journal-title":"Hosp Pediatr"},{"issue":"1","key":"zoi200923r60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/PRA.0000000000000437","article-title":"Availability of buprenorphine treatment in the 10 states with the highest drug overdose death rates in the United States.","volume":"26","author":"Flavin","year":"2020","journal-title":"J Psychiatr Pract"},{"key":"zoi200923r16","unstructured":"SAMHSA. Substance Abuse and Mental Health Services Administration. Buprenorphine practitioner locator. Accessed February 11, 2020. https:\/\/www.samhsa.gov\/medication-assisted-treatment\/practitioner-program-data\/treatment-practitioner-locator"},{"key":"zoi200923r17","unstructured":"Data.Medicare.gov . Physician Compare datasets. Updated October 16, 2020. Accessed February 11, 2020. https:\/\/data.medicare.gov\/data\/physician-compare"},{"key":"zoi200923r19","unstructured":"Agency for Healthcare Research and Quality. HCUP? Fast Stats: map of neonatal abstinence syndrome (NAS) among newborn hospitalizations. Updated August 27, 2020. Accessed February 11, 2020. https:\/\/www.hcup-us.ahrq.gov\/faststats\/NASMap"},{"key":"zoi200923r20","unstructured":"United States Department of Agriculture. Economic Research Service. Rural Urban Continuum Codes. Updated October 25, 2019. Accessed February 11, 2020. https:\/\/catalog.data.gov\/dataset\/rural-urban-continuum-codes#sec-dates"},{"key":"zoi200923r22","unstructured":"AAMC. Physician specialty data report. Number of people per active physician by specialty, 2017. Accessed September 4, 2020. https:\/\/www.aamc.org\/data-reports\/workforce\/interactive-data\/number-people-active-physician-specialty-2017"},{"key":"zoi200923r23","unstructured":"Doximity. Doximity 2019 physician compensation report. Published April 2, 2019. Accessed July 23, 2020. https:\/\/blog.doximity.com\/articles\/doximity-2019-physician-compensation-report-d0ca91d1-3cf1-4cbb-b403-a49b9ffa849f"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2774073\/nguemeni_tiako_2020_oi_200923_1607110897.80135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T06:19:59Z","timestamp":1618640399000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2774073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.29043","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,11]]}}}